The bill would for the first time limit drug copays for people with Medicare's "Part D" prescription plan, by capping patients' out-of-pocket costs at $3,100 a year starting in 2022.
By Ricardo Alonso-Zaldivar, Associated Press
Senators grilled CEOs of seven major drug companies on Tuesday over high prescription drug prices that are a drain on Medicare and Medicaid and a burden to millions of Americans. The extraordinary public accounting was a sign that Congress and…
By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press
Republican Sen. Chuck Grassley and Democratic Sen. Richard Blumenthal are proposing that special counsel Robert Mueller be required to submit a report to Congress and the public when his Russia investigation is complete.
By Mary Clare Jalonick, Associated Press
The Senate is expected to take up criminal justice reform before year end. A proposed overhaul would lower mandatory minimum sentences for drug crimes, ban the shackling of pregnant prisoners and ensure inmates stay closer to family. Judy Woodruff talks…
By Associated Press
Republicans have slim 11-10 majority on the committee.
By Joshua Barajas
Grassley said the committee has tried to request evidence from attorneys representing two other women who have accused Kavanaugh of sexual misconduct, and that attorneys have not cooperated.
By Associated Press
Senate Republicans are bringing in Arizona prosecutor Rachel Mitchell to handle questioning about allegations of sexual assault against Supreme Court nominee Brett Kavanaugh, describing her as tough, experienced and, above all, objective.
Yesterday I joined six former Hill staffers—who all, like me, experienced sexual misconduct while working in Congress—in urging federal lawmakers to finalize sexual harassment reform legislation. It’s now been almost a year since…
Demonstrators have congregated in a Senate office building to protest Republicans' handling of the sexual-assault accusation against Supreme Court nominee Brett Kavanaugh.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.